ArticleInternational journal of cancer2021

Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent and in combination with checkpoint-inhibitor therapy in mouse models of osteosarcoma.

Marlene Hennessy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.